BioStock: BiBBInstruments’ CEO: “Exciting times ahead”

So far this year, BiBBInstruments has obtained an FDA market clearance for EndoDrill GI, completed a fully subscribed directed share issue, published positive data for EndoDrill URO and received two patent approvals in Europe. On the agenda now is an expected CE certificate according to MDR for market approval in Europe of the entire EndoDrill product series, as well as the premiere of the EndoDrill GI system for specialists in endoscopic ultrasound. In the US, a clinical evaluation of the EndoDrill GI will soon begin at hospitals using endoscopic ultrasound.

Read the article at biostock.se:

https://www.biostock.se/en/2023/11/bibbinstruments-ceo-exciting-times-ahead/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/